应用人工智能技术诊治肝脏疾病研究进展

doi:10.3969/j.issn.1672-5069.2023.02.036

Abstract

Abstract: Objective At present, the artificial intelligence (AI) has been widely used in many fields, and it also applied in medical diagnosis and treatment. In this paper, we mainly reviewed the AI research on the diagnosis, management and prognosis of patients with in liver diseases, in order to provide more effective measures. Finally, the future development of AI in the field of liver disease study is prospected.

Key words: Viral hepatitis, Cirrhosis, Liver failure, Artificial intelligence, Management

Wu Peng, Gao Liucun, Tang Shanhong. Artificial intelligence in the diagnosis and treatment of patients with liver diseases[J]. Journal of Practical Hepatology, 2023, 26(2): 293-296.

References

[1] Krishna AB, Tanveer A, Bhagirath PV, et al. Role of artificial intelligence in diagnostic oral pathology-A modern approach. J Oral Maxillofac Pathol, 2020, 24(1): 152-156.
[2] Ahn JC, Connell A, Simonetto DA, et al. Application of artificial intelligence for the diagnosis and treatment of liver diseases. Hepatology, 2021, 73(6): 2546-2563.
[3] Spann A, Yasodhara A, Kang J, et al. Applying machine learning in liver disease and transplantation: A comprehensive review. Hepatology, 2020, 71(3): 1093-1105.
[4] Li H, Yan L, Shi Y, et al. Hepatitis B virus infection: Overview. Adv Exp Med Biol, 2020, 1179: 1-16.
[5] Khan S, Ullah R, Khan A, et al. Analysis of hepatitis B virus infection in blood sera using Raman spectroscopy and machine learning. Photodiagnosis Photodyn Ther, 2018, 23: 89-93.
[6] Tong D, Chen C, Zhang J, et al. Application of Raman spectroscopy in the detection of hepatitis B virus infection. Photodiagnosis Photodyn Ther, 2019, 28: 248-252.
[7] Jennison E, PateL J, Scorletti E, et al. Diagnosis and management of non-alcoholic fatty liver disease. Postgrad Med J, 2019, 95(1124): 314-322.
[8] Cao W, An X, Cong L, et al. Application of deep learning in quantitative analysis of 2-dimensional ultrasound imaging of nonalcoholic fatty liver disease. J Ultrasound Med, 2020, 39(1): 51-59.
[9] Saadeh S, Younossi ZM, Remer EM, et al. The utility of radiological imaging in nonalcoholic fatty liver disease. Gastroenterology, 2002, 123(3): 745-750.
[10] Canbay A, Kalsch J, Neumann U, et al. Non-invasive assessment of NAFLD as systemic disease-A machine learning perspective. PLoS One, 2019, 14(3): e0214436.
[11] Yip TC, Ma AJ, Wong VW, et al. Laboratory parameter-based machine learning model for excluding non-alcoholic fatty liver disease (NAFLD) in the general population. Aliment Pharmacol Ther, 2017, 46(4): 447-456.
[12] Asrani SK, Devarbhavi H, Eaton J, et al. Burden of liver diseases in the world. J Hepatol, 2019, 70(1): 151-171.
[13] Myera RP, Benhamou Y, Imbert-Bismut F, et al. Serum biochemical markers accurately predict liver fibrosis in HIV and hepatitis C virus co-infected patients. AIDS, 2003, 17(5): 721-725.
[14] Piccinino F, Sagnelli E, Pasquale G, et al. Complications following percutaneous liver biopsy. A multicentre retrospective study on 68, 276 biopsies. J Hepatol, 1986, 2(2): 165-173.
[15] Lee JH, Joo I, Kang TW, et al. Deep learning with ultrasonography: automated classification of liver fibrosis using a deep convolutional neural network. Eur Radiol, 2020, 30(2): 1264-1273.
[16] Wei R, Wang J, Wang X, et al. Clinical prediction of HBV and HCV related hepatic fibrosis using machine learning. EBioMedicine, 2018, 35: 124-132.
[17] Banerjee R, Das A, Ghoshal UC, et al. Predicting mortality in patients with cirrhosis of liver with application of neural network technology. J Gastroenterol Hepatol, 2003, 18(9): 1054-1060.
[18] Marozas M, Zykus R, Sakalauskas A, et al. Noninvasive evaluation of portal hypertension using a supervised learning technique. J Healthc Eng, 2017, 2017: 6183714.
[19] Hong WD, Zhu QH, Huang ZM, et al. Predictors of esophageal varices in patients with HBV-related cirrhosis: a retrospective study. BMC Gastroenterol, 2009, 9: 11.
[20] Dong TS, Kalani A, Aby ES, et al. Machine learning-based development and validation of a scoring system for screening high-risk esophageal varices. Clin Gastroenterol Hepatol, 2019, 17(9): 1894-1901.
[21] Wang X, Shen C, Yang J, et al. Alpha-fetoprotein as a predictive marker for patients with hepatitis B-related acute-on-chronic liver failure. Can J Gastroenterol Hepatol, 2018, 2018: 1232785.
[22] Garcia MS, Agarwal B, Mookerjee RP, et al. An accurate data preparation approach for the prediction of mortality in ACLF patients using the CANONIC dataset. Annu Int Conf IEEE Eng Med Biol Soc, 2019, 2019: 1371-1377.
[23] Speiser JL, Lee WM, Karvellas CJ, et al. Predicting outcome on admission and post-admission for acetaminophen-induced acute liver failure using classification and regression tree models. PLoS One, 2015, 10(4): e0122929.
[24] Speiser JL, Karvellas CJ, Wolf BJ, et al. Predicting daily outcomes in acetaminophen-induced acute liver failure patients with machine learning techniques. Comput Methods Programs Biomed, 2019, 175: 111-120.
[25] Huang S, Yang J, Fong S, et al. Artificial intelligence in cancer diagnosis and prognosis: Opportunities and challenges. Cancer Lett, 2020, 471: 61-71.
[26] Marya NB, Powers PD, Fujii-Lau L, et al. Application of artificial intelligence using a novel EUS-based convolutional neural network model to identify and distinguish benign and malignant hepatic masses. Gastrointest Endosc, 2021, 93(5): 1121-1130.
[27] Hamm CA, Wang CJ, Savic LJ, et al. Deep learning for liver tumor diagnosis part I: development of a convolutional neural network classifier for multi-phasic MRI. Eur Radiol, 2019, 29(7): 3338-3347.
[28] Sun C, Xu A, Liu D, et al. Deep learning-based classification of liver cancer histopathology images using only global labels. IEEE J Biomed Health Inform, 2020, 24(6): 1643-1651.
[29] Saillard C, Schmauch B, Laifa O, et al. Predicting survival after hepatocellular carcinoma resection using deep learning on histological slides. Hepatology, 2020, 72(6): 2000-2013.
[30] Briceno J, Cruz-Ramirez M, Prieto M, et al. Use of artificial intelligence as an innovative donor-recipient matching model for liver transplantation: results from a multicenter Spanish study. J Hepatol, 2014, 61(5): 1020-1028.
[31] Khosravi B, Pourahmad S, Bahreini A, et al. Five years survival of patients after liver transplantation and its effective factors by neural network and Cox poroportional hazard regression models. Hepat Mon, 2015, 15(9): e25164.
[32] Andres A, Montano-Loza A, Greiner R, et al. A novel learning algorithm to predict individual survival after liver transplantation for primary sclerosing cholangitis. PLoS One, 2018, 13(3): e0193523.
[33] Lee HC, Yoon SB, Yang SM, et al. Prediction of acute kidney injury after liver transplantation: Machine learning approaches vs. Logistic regression model. J Clin Med, 2018, 7(11): 428.
[34] Lv C, Zhang Y, Chen X, et al. New-onset diabetes after liver transplantation and its impact on complications and patient survival. J Diabetes, 2015, 7(6): 881-890.
[35] Bhat V, Tazari M, Watt KD, et al. New-onset diabetes and preexisting diabetes are associated with comparable reduction in long-term survival after liver transplant: A machine learning approach. Mayo Clin Proc, 2018, 93(12): 1794-1802.

Artificial intelligence in the diagnosis and treatment of patients with liver diseases

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	Deng Kexin, Luo Hongchun. Evaluation of bacterial infection by common hematological indexes in patients with acute-on-chronic liver failure [J]. Journal of Practical Hepatology, 2023, 26(2): 242-245.
[2]	Cheng Xiaoyan, Zhao Aiming, Li Haidan, et al.. Distribution of pathogens and serum Th1/Th2 cytokine changes in patients with hepatitis B virus related acute-on-chronic liver failure and nosocomial infections [J]. Journal of Practical Hepatology, 2023, 26(2): 246-249.
[3]	Lu Jinshuai, You Daofeng, Li Nan. Clinical implications of peripheral blood mononuclear cell IP-10 and COX-2 mRNA levels in patients with hepatitis B virus-related acute-on-chronic liver failure [J]. Journal of Practical Hepatology, 2023, 26(2): 250-253.
[4]	Cheng Yang, Zhang Feng, Wang Xixuan, et al.. Comparison of clinical efficacy of carvedilol and propranolol in preventing esophagogastric varices bleeding in patients with liver cirrhosis [J]. Journal of Practical Hepatology, 2023, 26(2): 254-257.
[5]	Li Jiaxing, Wu Lixia, Yin Chenglong, et al.. Laparoscopic splenectomy and pericardial devascularization in treatment of cirrhotics with esophageal varice and its impact on portal hemodynamics [J]. Journal of Practical Hepatology, 2023, 26(2): 258-261.
[6]	Zhang Bin, Zhao Yuliang, Yan Guobei. Efficacy of hUCB-MNC and hUC-MSC transfusion in patients with decompensated hepatitis B liver cirrhosis [J]. Journal of Practical Hepatology, 2023, 26(2): 262-265.
[7]	Zhou Qiujuan, Zhu Yiming, Ma Yuhang, et al.. Improvement of hypersplenism in patients hepatitis B cirrhosis after TIPS and PSE combination treatment [J]. Journal of Practical Hepatology, 2023, 26(2): 266-269.
[8]	Huang Shulun, He Shengduo, Xu Xiaoyuan, et al.. Efficacy of partial enteral nutrition and octreotide treatment for liver cirrhotic patient with chylous ascites:a case report [J]. Journal of Practical Hepatology, 2023, 26(2): 290-292.
[9]	Chinese Society of Hepatology, Chinese Society of Gastroenterology, and Chinese Society of Digestive Endoscopology of Chinese Medical Association. Guidelines on the Management of EVB in Cirrhotic Portal Hypertension [J]. Journal of Practical Hepatology, 2023, 26(2): 0-S4.
[10]	Liu Haixia, Zhu Yunxia, Duan Zhonghui, et al. Changes of prognosis and causes of death of patients with acute fatty liver of pregnancy in the past two decades [J]. Journal of Practical Hepatology, 2023, 26(1): 55-58.
[11]	Wu Chengyong, Chen Chong, Liu Wenyan, et al. Prevalence of bacterial infection in patients with HBV-related acute-on-chronic liver failure [J]. Journal of Practical Hepatology, 2023, 26(1): 59-62.
[12]	Shao Simeng, Gao Feng, Jiang Lei, et al. Polarization of peripheral blood macrophages and PBMCs TXNIP/NLRP3 mRNA changes in patients with hepatitis B virus acute-on-chronic liver failure [J]. Journal of Practical Hepatology, 2023, 26(1): 63-66.
[13]	Zhu Xinwen, Wang Weibing, Yuan Fubing, et al. Combination of NLR and serum IL-6 level in predicting 28-day mortality in patients with acute-on-chronic hepatitis B liver failure [J]. Journal of Practical Hepatology, 2023, 26(1): 67-70.
[14]	Xu Haibo, Su Huiting, Xiong Yiping, et al. Changes of peripheral blood dNLR, MLR and SII in patients with hepatitis B cirrhosis [J]. Journal of Practical Hepatology, 2023, 26(1): 71-74.
[15]	Li Susu, Dong Yuan, Jia Haoyan, et al. Observation of ornithine aspartate at base of colon dialysis in treatment of patients with hepatic encephalopathy [J]. Journal of Practical Hepatology, 2023, 26(1): 75-78.